CDH17 and adenocarcinoma: A significant statistical association was found between CDH17 immunohistochemical expression in tumor core/tumor emboli/lymph node metastasis and histological type (p = 0.001/p = 0.023/p = 0.022) (Table 1 and Table 2), with high CDH17 levels being more associated with adenocarcinoma NOS cases.